CD4 and breast cancer: The complexity of CD4+ T lymphocytes (presumably Th2 or Tregs or both) in conjunction with CD8+ T lymphocytes and CD68+ tumor-associated macrophages (TAMs) were also reported that could be predictive of overall survival (OS) and relapse-free survival (RFS) in node-positive human BC [19,21].